Quantitative characterization and analysis of the dynamic NF-κB response in microglia

BMC Bioinformatics

Volumn 12, Issue , 2011, Pages

  Sheppard, Patrick W ^a   Sun, Xiaoyun ^b   Emery, John F ^b   Giffard, Rona G ^b   Khammash, Mustafa ^a  

^a University of California   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL SPECIES; BIOLOGICAL MECHANISMS; INFLAMMATORY STIMULI; MODULAR PROCEDURES; NEW MATHEMATICAL MODEL; QUANTITATIVE CHARACTERIZATION; REGULATORY MECHANISM; UBIQUITIN-PROTEASOME SYSTEM;

CELL CULTURE; DYNAMIC RESPONSE; FEEDBACK; GENE EXPRESSION; SIGNALING; TOOLS;

DYNAMICS;

CYTOKINE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BRAIN ISCHEMIA; CELL LINE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; MICROGLIA; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN ISCHEMIA; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; I-KAPPA B KINASE; INFLAMMATION; MICE; MICROGLIA; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959814264     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-276     Document Type: Article

References (47)

1. O'Neill LA, Kaltschmidt C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997, 20(6):252-258. 10.1016/S0166-2236(96)01035-1, 9185306.
2. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M. NF-kB is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999, 5:554-559. 10.1038/8432, 10229233.
3. John GR, Lee SC, Brosnan CF. Cytokines: powerful regulators of glial cell activation. Neuroscientist 2003, 9(1):10-22. 10.1177/1073858402239587, 12580336.
4. Hoffman A, Levchenko A, Scott ML, Baltimore D. The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation. Science 2002, 298:1241-1245. 10.1126/science.1071914, 12424381.
5. Nelson D, Ihekwaba A, Elliott M, Johnson J, Gibney C, Foreman B, Nelson G, See V, Horton C, Spiller D, et al. Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression. Science 2004, 306(5696):704-708. 10.1126/science.1099962, 15499023.
6. Tay S, Hughey JJ, Lee TK, Lipniacki T, Quake SR, Covert MW. Single-cell NF-κB dynamics reveal digital activation and analogue information processing. Nature 2010, 466:267-271. 10.1038/nature09145, 3105528, 20581820.
7. Hayden MS, Ghosh S. Shared Principles in NF-κB Signaling. Cell 2008, 132(3):344-362. 10.1016/j.cell.2008.01.020, 18267068.
8. Chen Z, Hagler J, Palombella V, Melandri F, Scherer D, Ballard D, Maniatis T. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 1995, 9(13):1586-1597. 10.1101/gad.9.13.1586, 7628694.
9. Suzuki H, Chiba T, Kobayashi M, Takeuchi M, Suzuki T, Ichiyama A, Ikenoue T, Omata M, Furuichi K, Tanaka K. IκBa Ubiquitination Is Catalyzed by an SCF-like Complex Containing Skp1, Cullin-1, and Two F-Box/WD40-Repeat Proteins, βTrCP1 and βTrCP2. Biochem Biophys Res Commun 1999, 256(1):127-132. 10.1006/bbrc.1999.0289, 10066435.
10. Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, Manning AM, Andersen JS, Mann M, Mercurio F, Ben-Neriah Y. Identification of the receptor component of the IκBa-ubiquitin ligase. Nature 1998, 396(6711):590-594. 10.1038/25159, 9859996.
11. Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1995, 92(23):10599-10603. 10.1073/pnas.92.23.10599, 40659, 7479848.
12. Pahl H. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18(49):6853-6866. 10.1038/sj.onc.1203239, 10602461.
13. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kB signalling. Nature 2004, 430(7000):694-699. 10.1038/nature02794, 15258597.
14. Ashall L, Horton CA, Nelson DE, Paszek P, Harper CV, Sillitoe K, Ryan S, Spiller DG, Unitt JF, Broomhead DS, et al. Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription. Science 2009, 324(5924):242-246. 10.1126/science.1164860, 2785900, 19359585.
15. Basak S, Kim H, Kearns JD, Tergaonkar V, O'Dea E, Werner SL, Benedict CA, Ware CF, Ghosh G, Verma IM, et al. A Fourth IκB Protein within the NF-κB Signaling Module. Cell 2007, 128(2):369-381. 10.1016/j.cell.2006.12.033, 1831796, 17254973.
16. Covert MW, Leung TH, Gaston JE, Baltimore D. Achieving Stability of Lipopolysaccharide-Induced NF-κB Activation. Science 2005, 309:1854-1857. 10.1126/science.1112304, 16166516.
17. Krishna S, Jensen MH, Sneppen K. Minimal model of spiky oscillations in NF-κB signaling. Proc Natl Acad Sci USA 2006, 103(29):10840-10845. 10.1073/pnas.0604085103, 1544135, 16829571.
18. Lipniacki T, Paszek P, Brasier AR, Luxon B, Kimmel M. Mathematical model of NF-κB regulatory module. J Theor Biol 2004, 228(2):195-215. 10.1016/j.jtbi.2004.01.001, 15094015.
19. Cheong R, Hoffmann A, Levchenko A. Understanding NF-kB signaling via mathematical modeling. Mol Syst Biol 2008, 4(192).
20. Cheong R, Bergmann A, Werner SL, Regal J, Hoffmann A, Levchenko A. Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-κ Doses. J Biol Chem 2006, 281(5):2945-2950.
21. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immun 2000, 18(1):621-663. 10.1146/annurev.immunol.18.1.621, 10837071.
22. Werner SL, Barken D, Hoffmann A. Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity. Science 2005, 309(5742):1857-1861. 10.1126/science.1113319, 16166517.
23. Lillacci G, Khammash M. Parameter estimation and model selection in computational biology. PLoS Comput Biol 2010, 6(3):e1000696. 10.1371/journal.pcbi.1000696, 2832681, 20221262.
24. Park SG, Lee T, Kang HY, Park K, Cho K-H, Jung G. The influence of the signal dynamics of activated form of IKK on NF-κB and anti-apoptotic gene expressions: A systems biology approach. FEBS Letters 2006, 580:822-830. 10.1016/j.febslet.2006.01.004, 16413545.
25. Werner SL, Kearns JD, Zadorozhnaya V, Lynch C, O'Dea E, Boldin MP, Ma A, Baltimore D, Hoffmann A. Encoding NF-κB temporal control in response to TNF: distinct roles for the negative regulators IκBα and A20. Genes Dev 2008, 22(15):2093-2101. 10.1101/gad.1680708, 2492747, 18676814.
26. Lipniacki T, Puszynski K, Paszek P, Brasier AR, Kimmel M. Single TNFα trimers mediating NF-κB activation: stochastic robustness of NF-κB signaling. BMC Bioinformatics 2007, 8:376. 10.1186/1471-2105-8-376, 2222661, 17925009.
27. Delhase M, Hayakawa M, Chen Y, Karin M. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science 1999, 284(5412):309-313. 10.1126/science.284.5412.309, 10195894.
28. Mauro C, Pacifico F, Lavorgna A, Mellone S, Iannetti A, Acquaviva R, Formisano S, Vito P, Leonardi A. ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-κB. J Biol Chem 2006, 281(27):18482-18488. 10.1074/jbc.M601502200, 16684768.
29. Zhang SQ, Kovalenko A, Cantarella G, Wallach D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation. Immunity 2000, 12(3):301-311. 10.1016/S1074-7613(00)80183-1, 10755617.
30. Ihekwaba A, Broomhead D, Grimley R, Benson N, Kell D. Sensitivity analysis of parameters controlling oscillatory signalling in the NF-κB pathway: the roles of IKK and IκBα. Systems Biol 2004, 1:93-103.
31. Ihekwaba AE, Broomhead DS, Grimley R, Benson N, White MR, Kell DB. Synergistic control of oscillations in the NF-κB signalling pathway. IEE Proc Systems Biol 2005, 152(3):153-160.
32. Joo J, Plimpton S, Martin S, Swiler L, Faulon JL. Sensitivity Analysis of a Computational Model of the IKK-NF-kappaB-IkappaBalpha-A20 Signal Transduction Network. Ann N Y Acad Sci 2007, 1115:221-239. 10.1196/annals.1407.014, 17934057.
33. Yue H, Brown M, Knowles J, Wang H, Broomhead DS, Kell DB. Insights into the behaviour of systems biology models from dynamic sensitivity and identifiability analysis: a case study of an NF-κB signalling pathway. Mol Biosyst 2006, 2(12):640-649. 10.1039/b609442b, 17216045.
34. Lee TK, Denny EM, Sanghvi JC, Gaston JE, Maynard ND, Hughey JJ, Covert MW. A Noisy Paracrine Signal Determines the Cellular NF-κB Response to Lipopolysaccharide. Sci Signal 2009, 2:ra65. 10.1126/scisignal.2000599, 2778577, 19843957.
35. Paszek P, Ryan S, Ashall L, Sillitoe K, Harper CV, Spiller DG, Rand DA, White MRH. Population robustness arising from cellular heterogeneity. Proc Natl Acad Sci USA 2010, 107(25):11644-11649. 10.1073/pnas.0913798107, 2895068, 20534546.
36. Karin M. The beginning of the end: IκB kinase (IKK) and NF-κB activation. J Biol Chem 1999, 274(39):27339-27342. 10.1074/jbc.274.39.27339, 10488062.
37. Pierce NW, Kleiger G, Shan S, Deshaies RJ. Detection of sequential polyubiquitylation on a millisecond timescale. Nature 2009, 462(7273):615-619. 10.1038/nature08595, 2791906, 19956254.
38. Nakayama K, Hatakeyama S, Maruyama S, Kikuchi A, Onoé K, Good RA, Nakayama KI. Impaired degradation of inhibitory subunit of NF-κB (IκB) and β-catenin as a result of targeted disruption of the β-TrCP1 gene. Proc Natl Acad Sci USA 2003, 100(15):8752-8757. 10.1073/pnas.1133216100, 166385, 12843402.
39. Fuchs S, Spiegelman V, Kumar K. The many faces of β-TrCP E3 ubiquitin ligases: Reflections in the magic mirror of cancer. Oncogene 2004, 23(11):2028-2036. 10.1038/sj.onc.1207389, 15021890.
40. Read MA, Brownell JE, Gladysheva TB, Hottelet M, Parent LA, Coggins MB, Pierce JW, Podust VN, Luo RS, Chau V, alombella VJ. Nedd8 modification of cul-1 activates SCFβTrCP-dependent ubiquitination of IκBa. Mol Cell Biol 2000, 20(7):2326-2333. 10.1128/MCB.20.7.2326-2333.2000, 85397, 10713156.
41. Kawakami T, Chiba T, Suzuki T, Iwai K, Yamanaka K, Minato N, Suzuki H, Shimbara N, Hidaka Y, Osaka F, et al. NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J 2001, 20(15):4003-4012. 10.1093/emboj/20.15.4003, 149148, 11483504.
42. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A. Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice. Science 2000, 289(5488):2350-2354. 10.1126/science.289.5488.2350, 11009421.
43. Schomer-Miller B, Higashimoto T, Lee YK, Zandi E. Regulation of I kappa B Kinase (IKK) Complex by IKK gamma-dependent Phosphorylation of the T-loop and C Terminus of IKK beta. J Biol Chem 2006, 281(22):15268. 10.1074/jbc.M513793200, 16597623.
44. Kearns JD, Basak S, Werner SL, Huang CS, Hoffmann A. IκBε provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression. J Cell Biol 2006, 173(5):659-664. 10.1083/jcb.200510155, 2063883, 16735576.
45. Sillitoe K, Horton C, Spiller D, White M. Single-cell time-lapse imaging of the dynamic control of NF-κB signalling. Biochem Soc Trans 2007, 35:263-266. 10.1042/BST0350263, 17371255.
46. Csete ME, Doyle JC. Reverse Engineering of Biological Complexity. Science 2002, 295(5560):1664-1669. 10.1126/science.1069981, 11872830.
47. Fisher RA. Statistical methods for research workers. 1950, Edinburgh: Oliver and Boyd, 11.